Technology
The page describes the world’s first endovascular robot, designed to operate remotely with an internet connection.
remedyrobotics.comCrawled Nov 16, 2026
The page describes the world’s first endovascular robot, designed to operate remotely with an internet connection.
Axios reported in October 2025 that Remedy completed its first remote procedures.
In October 2026, Remedy’s CEO David Bell appeared on the *Wild Hearts* Podcast.
December 2024: Remedy Robotics has completed its First in Human clinical procedures.
December 2023: Remedy Robotics system is integrated into a clinical environment for the first time.
The page shares Remedy’s updates, insights, and news.
In September 2026, Remedy’s CEO David Bell participated in the *AI Inside the Health System* panel at *Imagination in Action: Silicon Valley*.
October 2025: Additional Coverage of Remedy's Partnership with the Australian Stroke Alliance
July 2026: Remedy is attending the SNIS annual meeting in Seattle
November 2025: Remedy is attending the SVIN annual meeting in Orlando
May 2025: Remedy Robotics will be participating in the Mayo Clinic's Cardiology & Radiology Innovation Summit.
In March 2025, Remedy’s CEO David Bell discussed the future of med-tech with Alan Cohen from DCVC at *LSI '25*.
In June 2024, Remedy’s CEO David Bell spoke at *Sunrise*, Australia’s premier startup conference, about med-tech innovation.
Join the team behind the world's first endovascular robot capable of operating from anywhere in the world with an internet connection.
All about the team behind world's first endovascular robot capable of operating from anywhere in the world with an internet connection.
AI-powered endovascular intervention for every patient, everywhere.
The world's first endovascular robot capable of operating from anywhere in the world with an internet connection.
Remedy Robotics secures $62 million in Series B funding to advance its robotic systems for cardiovascular care and endovascular interventions. The company specializes in AI-driven healthcare robotics, targeting precision medical procedures. Investors back the development of its proprietary robotic platforms for minimally invasive treatments.